<SEC-DOCUMENT>0001104659-24-071737.txt : 20240614
<SEC-HEADER>0001104659-24-071737.hdr.sgml : 20240614
<ACCEPTANCE-DATETIME>20240614160210
ACCESSION NUMBER:		0001104659-24-071737
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20240614
DATE AS OF CHANGE:		20240614
EFFECTIVENESS DATE:		20240614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celldex Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000744218
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				133191702
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280207
		FILM NUMBER:		241044611

	BUSINESS ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827
		BUSINESS PHONE:		908-200-7500

	MAIL ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AVANT IMMUNOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19980828

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	T CELL SCIENCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>tm2417017d1_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on June&nbsp;14, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 3.5in"><B>Registration No.&nbsp;333-
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CELLDEX THERAPEUTICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13-3191702</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. employer</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of incorporation or organization)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identification number)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Perryville III Building</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>53 Frontage Road, Suite&nbsp;220</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hampton, New Jersey 08827</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(908)&nbsp;200-7500</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices; zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Celldex Therapeutics,&nbsp;Inc. 2021 Omnibus
Equity Incentive Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full title of the plan)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sam Martin</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chief Financial Officer</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CELLDEX THERAPEUTICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Perryville III Building</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>53 Frontage Road, Suite&nbsp;220</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hampton, New Jersey 08827</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(908) 200-7500</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address and telephone number, including
area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Copies to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Anthony O. Pergola,&nbsp;Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Lowenstein Sandler LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1251 Avenue of the Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">New York, New York 10020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(212) 262-6700</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
 &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth
company&rdquo; in Rule&nbsp;12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 65%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer <FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer&#8239;<FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer <FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company&#8239;<FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company&#8239;<FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B)&nbsp;of the Securities Act.&#8239;<FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Registration Statement is being filed by the
registrant, Celldex Therapeutics,&nbsp;Inc. (the &ldquo;Company&rdquo;), for the purpose of registering an additional 3,200,000 shares
of common stock, par value $0.001 per share (&ldquo;Common Stock&rdquo;), to be issued under the Celldex Therapeutics,&nbsp;Inc. 2021
Omnibus Equity Incentive Plan (as amended, effective as of June&nbsp;13, 2024) (the &ldquo;2021 Plan&rdquo;), pursuant to General Instruction
E on Form&nbsp;S-8 (Registration of Additional Securities).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The contents of the original registration
statement on Form&nbsp;S-8 for the 2021 Plan filed on <A HREF="https://www.sec.gov/Archives/edgar/data/744218/000110465921081982/tm2119432d1_s8.htm">June&nbsp;16,
2021 (File No.&nbsp;333-257137)</A> and the registration statement on Form S-8 for the 2021 Plan filed on <A HREF="https://www.sec.gov/Archives/edgar/data/744218/000110465923073322/tm2318574d1_s8.htm">June 21, 2023 (File No. 333-272804)</A> are hereby incorporated by reference and made a part hereof. Any items in the Company&rsquo;s Registration Statements on
Form&nbsp;S-8 (File No.&nbsp;333-257137 and File No. 333-272804) not expressly changed hereby shall be as set forth in the Company&rsquo;s
Registration Statements on Form&nbsp;S-8 (File No.&nbsp;333-257137 and File No. 333-272804). The stockholders of the registrant approved amending the
2021 Plan for this purpose at the annual meeting of stockholders held on June&nbsp;13, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 3.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporation of Certain Documents by Reference</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Securities and Exchange Commission allows us
to &ldquo;incorporate&rdquo; into this registration statement information we file with other documents. This means that we may disclose
important information to you by referring to other documents that contain that information. The information incorporated by reference
is considered to be part of this registration statement, and information we file later with the Securities and Exchange Commission will
automatically update and supersede this information. We incorporate by reference the documents listed below, except to the extent information
in those documents is different from the information contained in this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></FONT></TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/744218/000141057824000076/cldx-20231231x10k.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2023, filed on February&nbsp;26, 2024.</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></FONT></TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/744218/000141057824000593/cldx-20240331x10q.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Quarterly Report on Form&nbsp;10-Q for the quarterly period ended March&nbsp;31, 2024, filed on May&nbsp;6, 2024.</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></FONT></TD>
    <TD STYLE="text-align: justify">Our Current Reports on Form 8-K filed with the Commission on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/744218/000110465924029969/tm247553d1_8k.htm" STYLE="-sec-extract: exhibit">March 1, 2024</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/744218/000110465924071512/tm2417134d1_8k.htm" STYLE="-sec-extract: exhibit">June 14, 2024</A> (in
    each case except to the extent furnished but not filed).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Our Proxy Statement on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/744218/000110465924051634/tm242684d2_def14a.htm" STYLE="-sec-extract: exhibit">Schedule 14A, filed with the Commission on April 25, 2024</A> (solely with respect to those portions incorporated by reference into the Annual Report); and &nbsp;</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The description of the securities contained in the Company&rsquo;s Registration Statement on Form&nbsp;8-A filed under the </FONT>Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), as the description therein has been updated and superseded by the description of the Company&rsquo;s capital stock contained in <A HREF="https://www.sec.gov/Archives/edgar/data/744218/000110465923026701/cldx-20221231xex4d3.htm">Exhibit&nbsp;4.3</A> to the Company&rsquo;s Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2022, as filed with the Commission on February&nbsp;28, 2023, including any amendments or reports filed for the purpose of updating such description.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All documents subsequently filed by us with the
Securities and Exchange Commission pursuant to Sections 13(a), 13(c), 14 or 15(d)&nbsp;of the Exchange Act, prior to the filing of a post-effective
amendment to this registration statement, which indicates that all securities offered hereby have been sold or which deregisters all securities
then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be a part hereof from the
date of filing of such documents, except as to specific sections of such documents as set forth therein. Any statement contained in a
document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this
Registration Statement to the extent that a statement contained in any subsequently filed document, which also is deemed to be incorporated
by reference herein, modifies or supersedes such statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item 8.</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibits</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The exhibits accompanying this registration statement
are listed on the accompanying exhibit index.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 10%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
Number</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 88%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: right"><A HREF="tm2417017d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tm2417017d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Lowenstein Sandler LLP*</FONT></A></TD></TR>
  <TR>
    <TD STYLE="text-align: right"><A HREF="tm2417017d1_ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tm2417017d1_ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of PricewaterhouseCoopers LLP,&nbsp;Independent Registered Public Accounting Firm of Celldex Therapeutics,&nbsp;Inc.*</FONT></A></TD></TR>
  <TR>
    <TD STYLE="text-align: right"><A HREF="tm2417017d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tm2417017d1_ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Lowenstein Sandler LLP (filed as part of Exhibit&nbsp;5.1).*</FONT></A></TD></TR>
  <TR>
    <TD STYLE="text-align: right"><A HREF="#sp1-001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="#sp1-001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (contained on signature page&nbsp;to this registration statement on Form&nbsp;S-8)*</FONT></A></TD></TR>
  <TR>
    <TD STYLE="text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/744218/000110465924071512/tm2417134d1_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/744218/000110465924071512/tm2417134d1_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment No.&nbsp;2 to Celldex
    Therapeutics,&nbsp;Inc. 2021 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K filed on June 14, 2024)</FONT></A></TD></TR>
  <TR>
    <TD STYLE="text-align: right"><A HREF="tm2417017d1_ex-filingfees.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;107</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="tm2417017d1_ex-filingfees.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing Fee Table</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Filed herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="sp1-001"></A><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form&nbsp;S-8
and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City
of Hampton, State of New Jersey, on June&nbsp;14, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CELLDEX THERAPEUTICS,&nbsp;INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Anthony S. Marucci</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony S. Marucci</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sam Martin</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sam Martin</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Vice President and Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer and Principal Accounting Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">KNOW ALL BY THESE PRESENTS that each individual
whose signature appears below constitutes and appoints Anthony S. Marucci and Sam Martin, and each of them singly, as such person&rsquo;s
true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person&rsquo;s
name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration
Statement, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange
Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in
person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them,
may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; width: 28%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; width: 40%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; width: 28%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ ANTHONY S. MARUCCI</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Executive Officer, and Director</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony S. Marucci</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ SAM MARTIN</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Vice President,</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sam Martin</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and Treasurer <BR>
(Principal Financial and Accounting Officer)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ KAREN L. SHOOS</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director, Chair of the Board of Directors</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karen L. Shoos</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ KEITH L. BROWNLIE</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keith L. Brownlie</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ CHERYL L. COHEN</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cheryl L. Cohen</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ HERBERT J. CONRAD</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herbert J. Conrad</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ RITA I. JAIN, M.D, </FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rita I. Jain, M.D.</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ JAMES J. MARINO</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James J. Marino</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ GARRY A. NEIL, M.D.</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garry A. Neil, M.D.</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ HARRY H. PENNER,&nbsp;JR.</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;14, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harry H. Penner,&nbsp;Jr.</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm2417017d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2417017d1_ex5-1iimg001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June&nbsp;14, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Celldex Therapeutics,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Perryville III Building</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">53 Frontage Road, Suite&nbsp;220</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hampton, New Jersey 08827</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Re: <U>Registration Statement on Form&nbsp;S-8</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have acted as counsel to Celldex Therapeutics,&nbsp;Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the Company&rsquo;s filing on the date hereof with the Securities
and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) of a Registration Statement on Form&nbsp;S-8 (the &ldquo;<U>Registration Statement</U>&rdquo;)
under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;). The Registration Statement relates to the registration
of an additional 3,200,000 shares (the &ldquo;<U>Shares</U>&rdquo;) of the Company&rsquo;s common stock, par value $0.001 per share (the
 &ldquo;<U>Common Stock</U>&rdquo;), issuable pursuant to the Celldex Therapeutics,&nbsp;Inc. 2021 Omnibus Equity Incentive Plan (as amended,
effective as of June&nbsp;13, 2024) (the &ldquo;<U>2021 Plan</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with rendering this opinion, we have
examined the 2021 Plan and the amendment thereto and such corporate records, certificates and other documents and such questions of law
as we have considered necessary and appropriate for the purposes of this opinion. In such examination, we have assumed the genuineness
of all signatures, the legal capacity of all natural persons, the authenticity of all documents submitted to us as originals, the conformity
of original documents of all documents submitted to us as certified, conformed or photostatic copies and the authenticity of the originals
of such latter documents. As to any facts material to our opinion, we have, when relevant facts were not independently established, relied
upon the Registration Statement and the aforesaid records, certificates and documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We assume that the Company has sufficient unissued
and unreserved shares of Common Stock and (or will validly amend its certificate of incorporation, to authorize a sufficient number of
shares of Common Stock prior to the issuance thereof) available for issuance as provided in the Registration Statement and any related
amendment thereto or prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on the foregoing, and subject to the qualifications
stated herein, we are of the opinion that the Shares, upon issuance and delivery as contemplated by the 2021 Plan, will be validly issued,
fully paid and nonassessable outstanding shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The opinion expressed herein is limited to the
corporate laws of the State of Delaware, as in effect on the date hereof, and we express no opinion as to the effect on the matters covered
by this letter of the laws of any other jurisdiction. We assume no obligation to advise you of facts or circumstances that come to our
attention or changes in law that occur which could affect the opinions contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We hereby consent to the filing of this opinion
as an exhibit to the Registration Statement and to the references to this firm in the Registration Statement. In giving such consent,
we do not thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act, or
the rules&nbsp;and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Lowenstein Sandler LLP</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lowenstein Sandler LLP</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>tm2417017d1_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">We hereby consent to the incorporation by reference in this Registration
Statement on Form&nbsp;S-8 of Celldex Therapeutics,&nbsp;Inc. of our report dated February&nbsp;26, 2024 relating to the financial statements
and the effectiveness of internal control over financial reporting, which appears in Celldex Therapeutics Inc.'s Annual Report on Form&nbsp;10-K
for the year ended December&nbsp;31, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ PricewaterhouseCoopers LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boston, Massachusetts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June&nbsp;14, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>tm2417017d1_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit&nbsp;107</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION OF FILING FEE TABLE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form&nbsp;S-8</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form&nbsp;Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Celldex Therapeutics,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Table 1: Newly Registered Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; width: 13%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Security<BR>
Type</B></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-top: Black 1pt solid; border-right: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; width: 26%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title of securities<BR>
to be registered</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-top: Black 1pt solid; border-right: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee Calculation<BR>
Rule</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-top: Black 1pt solid; border-right: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount to <BR>
be<BR>
registered(1)</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-top: Black 1pt solid; border-right: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; width: 7%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proposed</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>maximum</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>offering</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>price</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>per share(2)</B></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-top: Black 1pt solid; border-right: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; width: 13%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proposed<BR>
maximum<BR>
aggregate<BR>
offering price(2)</B></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-top: Black 1pt solid; border-right: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee Rate</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-top: Black 1pt solid; border-right: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount<BR>
 of<BR>
registration<BR>
fee(2)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock, $0.001 par value per share</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule&nbsp;457(c)&nbsp;and Rule&nbsp;457(h)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,200,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$35.015</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$112,048,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00014760</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$16,538.28</FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt 2pt; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Offering Amounts</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$112,048,000</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$16,538.28</FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="border-left: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fee Offsets(3)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash; </FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="border-left: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Fee Due</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding: 3pt 2pt; white-space: nowrap; vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$16,538.28</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rule&nbsp;416(a)&nbsp;under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this Registration Statement shall also cover any additional shares of the Company&rsquo;s common stock that become issuable under the Company&rsquo;s 2021 Omnibus Equity Incentive Plan (the &ldquo;Plan&rdquo;) in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without the Company&rsquo;s receipt of consideration that increases the number of the outstanding shares of the Company&rsquo;s common stock. </FONT></TD></TR>

<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rules&nbsp;457(c)&nbsp;and (h)&nbsp;under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price are estimated for the purpose of calculating the amount of the registration fee and are based on the average of the high and low sales price of the Company&rsquo;s common stock as reported on the NASDAQ Stock Market on June&nbsp;11, 2024. </FONT></TD></TR>

<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Registrant does not have any fee offsets. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2417017d1_ex5-1iimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2417017d1_ex5-1iimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !. /@# 2(  A$! Q$!_\0
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M]:_X+U_M">/?V=O^"7?[2'CGX9ZA/X=\8ZU#X1^&%IXB\I_-T'3OB3XY\/\
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M^!]'?PAH=_\ %+Q@FJR>*M<O(3JEG'<:6UI!HZWS7%VLIAB_6#PO_P ')/\
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M"R%HD>=M@VVY1I#'R^)T*E+.Z%3V<W%T(0A)0DTYPG9IM)J.L7K)J.VNJO\
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M&I/B+XG^%7BW2_![7NI:%=S3> GO=7U#0X]/N=3VWUO>ZE;S" 2682?\A?\
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MTGXF:SJFI^(;S0?$T%]IT4EHFH>(-;U6T\0306LFG:CJ$<D>F29!3["\6?\
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M!\:>,O$_P_U'05OK>&.'R[:[C\,:M/)?"*-+-;F"T,<B@3."YHZZ_@S\!/\
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"_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
